If you need more lookups,
subscriptions start at $34 USD/month.
Gary Waanders Location
Switzerland
Gary Waanders Work
2021 -now Head of Investor Relations and Communications @
2019 -2021 Vice President Investor Relations @
2017 -2019 Managing Director - UK Healthcare Research @ Bryan, Garnier & Co.
2014 -2017 Director, Healthcare Research @
2005 -2013 Director, Equity Research @
2001 -2005 Biotech Analyst @
1997 -1999 Project Leader - Cancer Vaccines and Drug Delivery Systems @
1990 -1997 Post-doctoral Fellow @
Gary Waanders Education
Durham University
MBA (Business Administration)
1999-2000
Monash University
BSC (Hons), PhD (Immunology)
1981-1990
Gary Waanders Skills
Biotechnology
IPO
Investment Banking
Valuation
Financial Modeling
Due Diligence
Mergers
Equities
Financial Analysis
Investments
Private Equity
Hedge Funds
Cancer
Business Development
Business Strategy
Restructuring
Corporate Development
Mergers & Acquisitions
Equity Research
Venture Capital
Emerging Markets
Capital Markets
Equity Capital Markets
Equity Valuation
Investment Management
Life Sciences
Strategy
Pharmaceutical Industry
Investor Relations
Finance
Healthcare
Strategic Planning
Molecular Biology
Change Management
Project Management
Mergers and Acquisitions
Cell Culture
Leadership
Research
Gary Waanders Summary
Gary Waanders, based in Switzerland, is currently a Head of Investor Relations and Communications at AC Immune. Gary Waanders brings experience from previous roles at Medigene AG, Bryan, Garnier & Co., Zeus Capital and Nomura Code Securities. Gary Waanders holds a 1999 - 2000 MBA in Business Administration @ Durham University. With a robust skill set that includes Biotechnology, IPO, Investment Banking, Valuation, Financial Modeling and more. Gary Waanders has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Gary Waanders?
Find contact details for 700 million professionals.